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Abstract: Pharmaceutical active compounds, including hundreds of different substances, are counted
among the emerging contaminants in waterbodies, whose presence raises a growing concern for
the ecosystem. Drugs are metabolized and excreted mainly through urine as an unchanged active
ingredient or in the form of metabolites. These emerging contaminants are not effectively removed
with the technologies currently in use, making them a relevant environmental problem. This study
proposes the treatment of urine and water at the source that can allow an easier removal of dissolved
drugs and metabolites. The treatment of synthetic urine, with dissolved ibuprofen as a model
compound, by adsorption, using various classes of inorganic materials, such as clays, hierarchical
zeolites and ordered mesoporous silica (MCM-41), is presented. A multi-technique approach involv-
ing X-ray powder diffraction, solid-state NMR, UV-Vis and Raman spectroscopies was employed
to investigate the adsorption process in inorganic adsorbents. Moreover, the uptake, the ensuing
competition, the efficiency and selectivity as well as the packing of the model compound in ordered
mesoporous silica during the incipient wetness impregnation process were all thoroughly monitored
by a novel approach, involving combined complementary time-resolved in situ 1H and 13C MAS
NMR spectroscopy as well as X-ray powder diffraction.
Keywords: pharmaceutical active compounds; adsorption; inorganic adsorbents; ibuprofen; X-ray pow-
der diffraction; solid-state NMR; Raman spectroscopy; time-resolved in situ studies; water remediation
1. Introduction
Water is a vital resource for all living organisms [1,2] and its availability, use and
quality are harmed by its unequal distribution, climate change, population growth, increas-
ing consumption, and waste; however, a crucial aspect regarding both water quality and
environmental impact is connected to pollution related to wastewater streams [3]. Besides
the so-called priority pollutants (PPs), related to significant risk for the aquatic environment
and human health, a multitude of compounds of anthropogenic origin, highlighting a
global problem, is to be tackled [4–6]. Among them, emerging contaminants (EC) can
potentially cause adverse effects on the ecosystem and human health [7]. Besides particles
as microplastics, a plethora of water-soluble emerging contaminants should be considered,
including pesticides, surfactants, artificial sweeteners, additives, drugs and active phar-
maceutical ingredients (APIs), compounds contained in products for care and personal
hygiene (pharmaceuticals and personal care products, PPCPs) and, in particular, endocrine-
disrupting compounds. The expansion of the pharmaceutical industry has promoted the
release and spread of pharmaceutical active compounds (PhACs) in the environment to
such an extent that today, they are counted among the emerging contaminants whose
presence raises a growing concern to the ecosystem [3,8–11].
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The PhACs category includes thousands of different compounds: in addition to
drugs employed for human use, it also includes those for veterinary use, illegal drugs and
metabolites of these compounds. The active pharmaceutical ingredients are specifically
engineered to be easily absorbed by organisms, to be bioactive even at low concentrations,
to have good stability and a prolonged half-life [12]. After administration, drugs are
metabolized and excreted mainly through the urine (64% of PhACs are eliminated by the
kidneys) and feces, either as unmodified compounds or in the form of metabolites [13].
Conventional wastewater treatment plants (WWTPs) are responsible for the reclama-
tion of wastewater from a wide selection of pollutants, but they are not specifically designed
for the removal of so-called emerging contaminants: none of the treatments currently in
use, conventional or advanced, nor their synergistic application, are able to guarantee a
complete removal of ECs from wastewater [7]. Part of this lack of efficiency against ECs
is due to the mixing and dilution of highly heterogeneous streams, i.e., outflows of the
hospital sector, which make a strong contribution to the load of pharmaceutical compounds
present in civil wastewater [14–17], together with rain, washing, rinsing, flushing, etc.
For the wide therapeutical address and the limited presence of side effects, nons-
teroidal anti-inflammatories (NSAIDs) are a therapeutic category whose incidence in the
environment is much studied; among them, ibuprofen (Ibu-Na), diclofenac (DIC), paraceta-
mol, ketoprofen (KET) and naproxen (NAP) have been observed in high concentration both
in tributaries and effluents of WWTPs. The overall results of more than 50 evaluation assays
conducted in 20 different countries reported the presence of diclofenac and ibuprofen in
more than 90% of the samples analyzed [18]. In addition, levels of tens of ng/g of Ibu-Na
and DIC have been observed in some marine species, such as in the mussels of Italian
Adriatic coasts [19] and in the Portuguese Atlantic coasts [20].
To date, adsorption is one of the most promising technologies for the removal of
active pharmaceutical ingredients from water, but one of the critical issues is the low
concentration of these molecules at the sewage plant level. Due to the relevance of this
anthropogenic problem, the present study was carried out, using ibuprofen as test API
and inorganic matrixes with different morphological and structural features as adsorbents.
The scope of this research is grounded on the possibility to treat water and urine directly
at the excretion source (i.e., hospitals or nursing homes) in order to allow a more efficient
removal of drugs, as the concentration is higher, and the treatment can be done in local
controlled environments.
This study aims at identifying potential inorganic adsorbents for the removal of active
pharmaceutical ingredients at low concentration as typically found in water and urine,
besides the plethora of other chemical species present in the latter complex medium. A
multi-technique approach involving X-ray powder diffraction, solid-state NMR, UV-Vis
and Raman spectroscopies was employed to investigate the non-covalent interactions
responsible for adsorption process. In order to follow the fundamental mechanistic steps of
encapsulation progression and complex molecular adsorption during the incipient wetness
impregnation process, a time-resolved in situ study is essential [21,22]. Therefore, the
local packing behavior of ibuprofen on the mesopores of MCM-41 was monitored, using a
combined complementary time-resolved in situ MAS NMR spectroscopy and powder XRD.
2. Materials and Methods
(±)-2-(4-Isobutylphenyl)propanoic acid or α-methyl-4-(isobutyl)phenylacetic acid,
more commonly known as ibuprofen in acid form, was acquired from Sigma-Aldrich
(St. Louis, MO, USA) and used as is. The sodium salt of ibuprofen (Ibu-Na) in granulated
formulation (with traces of NaHCO3) was a gift from a pharmaceutical company. Sodium
chloride, magnesium chloride, calcium chloride, potassium chloride, sodium phosphate,
sodium sulfate and sodium citrate tribasic dihydrate were supplied by Sigma-Aldrich
(Steinheim, Germany). Urea was supplied by Fluka (Buchs, Switzerland). Physiological
saline solution was purchased from Eurospital S.p.A (Trieste, Italy).
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Synthetic urine employed during experiments was prepared according to Table S1 [23–25].
To determine the expected amount of Ibu-Na in urine, the following considerations were taken.
The maximum prescribable daily dose is 1200 mg per day, and 70–90% of the administered
dose, both orally and intravenously, is excreted in the urine in the first 24 h following the
administration in the form of Ibu-Na and its catabolites, the latter representing the predominant
fraction. Therefore, only 1–5% of the active substance is recovered in the urine [26,27]. These




where [C] is the initial concentration in mg/L of drug in the urine; DDD (daily defined dose)
is the daily dose of the administered active ingredient (mg/day); F (%) is the unchanged
excreted drug fraction through the urine; Vurine is the average daily urine volume (1500 mL);
and 1000 is the conversion factor from mL to L. Table S2 summarizes the parameters and
the concentrations of active substance used. Citrate was selected as the interfering reference
metabolite, as reported in [25].
Fresh urine was prepared each day in order to avoid possible urea hydrolysis and
compositional changes due to aging and storage conditions. The contained salts were
dissolved in 1 L of deionized H2O, and the flask was wrapped with aluminum foil to
protect it from light and sonicated for 20 min. The pH was measured with a Hanna HI98108
pH meter (Smithfield, RI, USA) and adjusted with concentrated solutions of NaOH or HCl.
Inorganic adsorbents: Cloisite-Na+® and Cloisite-Ca++® are two natural bentonites
marketed as fillers for several applications (i.e., as polymer additives). They were pur-
chased from Southern Clay Products (Gonzales, TX, USA). The typical particle size is
between 2 µm and 13 µm; the interlamellar distance is 12 Å and 15 Å, respectively; and
the cation exchange capacities (CEC) provided by the manufacturer are 92.6 meq/100g
and 96 meq/100g, respectively. From the literature, it is known that the external specific
surface area (SSA) is 30–32 m2/g [28], but following exfoliation, it reaches values in the
range of 725–800 m2/g [29–31]. Molecular sieves (before and after activation) in pellet
form (3.2 mm) with a pore diameter of 4 Å were purchased from Sigma-Aldrich (Steinheim,
Germany). It was activated by thermally treating the material at 150 ◦C for 24 h.
Microporous NH4-ZSM-5 zeolite (SiO2/Al2O3 = 80) was provided by Zeolyst Interna-
tional (Kansas City, KS, USA). To obtain a hierarchical porous architecture (Hier ZSM-5), the
microporous NH4-ZSM-5 was desilicated following the procedure of Erigoni et al. [32]. Ac-
cording to the literature, the textural features show a SBET of 500 m2/g, Smeso of 215 m2/g,
Vpore_tot equal to 0.81 cm3/g, Vmeso cm3/g of 0.7, and pore diameteravg of 60 Å.
Calcined MCM-41 was purchased from Sigma-Aldrich (Steinheim, Germany); the
average pore size provided by the manufacturer is 21–27 Å, the specific surface area (SSA)
is ca. 1000 m2/g, and the pore volume is 0.98 cm3/g.
MCM-41 nanoparticles (MCM-41 NPs) were synthesized according to the procedure
by Miletto et al. [33]. In a typical synthesis, 1 g of CTAB (hexadecyltrimethylammonium
bromide) and 3.5 mL of 2M NaOH were added to 480 mL of deionized water in a three-
necked flask. The mixture was brought to 80 ◦C in an oil bath under magnetic stirring,
and then 5 mL of TEOS (tetraethyl orthosilicate) was added drop by drop. The reaction
mixture was further stirred for 2 h, after which the solution was cooled in an ice bath. The
precipitate obtained was separated by filtration and washed with deionized water (1 L)
and with ethanol (200 mL). The obtained material was dried at 60 ◦C overnight in an oven
and calcined at 560 ◦C in a tubular oven (Lenton, U.K.) with a temperature ramp of 2 ◦C
per minute in N2 flow; this temperature was maintained for 8 h in O2 flow. The textural
characteristics of spherical MCM-41 NPs were previously reported [34]. The average pore
size is 33 Å, the specific surface area (SSA) is 1097 m2/g and the pore volume is 1.36 cm3/g.
Merck grade silica gel was purchased from Sigma-Aldrich (Steinheim, Germany) (grade
60, 70–230 mesh, 60 Å, a SSA of 470–530 m2/ g, and a volume of 0.7–0.85 cm3/g). Fumed
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silica was provided by Sigma-Aldrich (Steinheim, Germany) as amorphous SiO2 with low a
density and high surface area (395 m2/g).
The Ibu-Na stock solution and the sorbents in a ratio of 5 g/L were dosed in 50 mL
polypropylene tube, subjected to vigorous stirring for 30 s with the aid of a vortex mixer
to obtain a good dispersion, and placed in a horizontal position in an incubator with
orbital stirring, Stuart SI 50 Bibby Scientific™ (Fisher Scientific, Rodano, Milano, Italy), at a
speed set at 180 oscillations per minute and at a temperature of 20 ◦C. After 2 h of contact,
the samples were centrifuged at 8000 rpm for 10 min. The supernatant was analyzed by
UV-visible spectrophotometry (Lambda900 Perkin Elmer, Waltham, MA, USA), using the
Lambert–Beer law.
A concentration calibration was performed, using the Ibu-Na stock solution and the
following dilutions; 1:2, 1:5, 1:10, 1:50 and 1:100. For each of the calibration equations,
obtained with a least squares linear regression, the resulting R2 was greater than 0.998. For
all samples, an aliquot of 3 mL and a quartz cuvette with an optical path of 1 cm were used.
As the LOD (limit of detection of the technique), the concentration corresponding to
the dilution 1:50 was considered: in each of the cases, the signal of further dilutions was not
statistically different from that of the solvent. The percentage adsorption of each material
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where Ci is the concentration of the drug stock solution [mol L−1]; Cf is the molar con-
centration of the supernatant at the end of the adsorption experiment [mol L−1]; V is the
volume of solution used in the test [L]; PM is the molecular weight of the drug [g mol−1];
M is the mass of adsorbent used [g]; and 1000 is the conversion factor from g to mg of
adsorbed active substance
Sample preparation for in situ experiments: A physical mixture was prepared by
mixing MCM-41 and Ibu-Na in equal amounts (weight-to-weight proportions) and grinding
on an agate mortar with a pestle. The prepared mixture was used for all the experiments.
MCM-41 was impregnated with Ibu-Na by the incipient wetness procedure. During the
in situ incipient wetness procedure for solid-sate NMR experiments, the physical mixture
was packed into a Kel-F insert and hydrated with a minimum amount of deuterated water
(Sigma-Aldrich, 99.9%), using a water to solid ratio (w/s) of around 1.3, and stirred for
one minute [21]. After that, the Kel-F insert was rapidly sealed with a plug and a screw
to suppress the escape of fluids, and fitted into a 4 mm rotor, closed with a Kel-F cap
and analyzed (Scheme S1). The sample temperature (25 ◦C) was set, using a temperature
control unit that was previously calibrated, using lead nitrate. Data acquisition was started
within 30 min of the initial contact of physical mixture with deuterated water. The time
intervals between patterns were varied, and selected patterns were plotted for clarity.
Similarly, for the in situ X-ray diffraction measurements, the physical mixture of MCM-
41 and Ibu-Na was mixed with a minimum amount of milliQ water to prepare a paste; this
was placed on a powder XRD airtight specimen holder, immediately covered with a dome
to minimize its interaction with the external atmosphere, and analyzed (Scheme S1).
The mechanoloaded sample was prepared by hand grinding a physical mixture of
MCM-41 and Ibu-Na, in the 2 to 1 weight-to-weight proportion in an agate mortar with
a pestle for 30 min. The powder XRD measurements on the sample showed no residual
peaks associated to crystalline Ibu-Na.
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The synthetic urine-based sample for Raman spectral measurements was prepared
according to the following procedure. The Ibu-Na stock solution and MCM-41 were
dosed in a ratio of 5 g/L in a 50 mL polypropylene tube, stirred for 30 s and placed in an
incubator with orbital stirring at a temperature of 20 ◦C. After 2 h of contact, the sample
was centrifuged at 8000 rpm for 10 min; the solid part was collected and dried overnight in
an oven at a temperature of 50 ◦C. The sample was named MCM-41\Ibu-Na_U. Its Raman
spectrum was measured without any further treatment.
The Raman spectra of the samples were acquired on a microRaman LabRam-HR
Evolution instrument, Horiba Jobin Yvon Scientific (Paris, France), equipped with a Peltier
effect-cooled CCD chamber, using a 532 nm Nd:YAG Laser with 80mW power as an
excitation source. The setting of the microspectrometer was as follows: 50X lens, slit
aperture 200 µm, and lattice 1800 lines/mm2. The acquisition time for each spectral
window and the number of accumulations were optimized for each individual material,
collected at room temperature. A silicon wafer with Raman signal at 520.7 cm−1 was
used to calibrate the instrument daily. The spectra were acquired with labspec6 software
(Horiba) and processed with OPUS-Spectroscopic software (Bruker Optik GmbH, Ettlingen,
Germany) by means of cosmic ray removal operations, when necessary, smoothing, and
baseline subtraction by polynomial reference curve generation. Unless otherwise specified,
the Raman spectra were normalized by applying the software’s Min–Max method.
Solid-state NMR spectra were acquired on a Bruker Avance III 500 spectrometer
(Faellanden, Switzerland) using a wide bore 11.75 Tesla magnet with operational frequencies
for 1H and 13C of 500.13 and 125.76 MHz, respectively. A 4 mm triple resonance probe, in
double resonance mode, with magic angle spinning (MAS) was employed in all the in situ
experiments. The samples were hydrated in a Kel-F insert that was fitted into a zirconia rotor
and spun at a MAS rate of 12 kHz, using a Bruker MAS III pneumatic unit. 1H MAS NMR
spectra were collected with an excitation pulse of 100 kHz. For the 13C cross-polarization (CP)
magic angle spinning experiments, the proton radio frequencies (RF) of 55 and 28 kHz were
used for initial excitation and decoupling, respectively. During the CP period, the 1H RF field
was ramped using 100 increments, whereas the 13C RF field was maintained at a constant
level. During the acquisition, proton decoupling was applied (spinal-64 decoupling scheme).
A moderate ramped radio frequency field of 55 kHz was used for spin locking, while the
carbon RF field was matched to obtain optimal signal (40 kHz). The delays, d1, between
accumulations were 3 and 2 s for 13C and 1H, respectively. The chemical shifts are reported
using δ scale and are externally referenced to TMS at 0 ppm.
Additional 1H and 13C NMR measurements were done in the liquid state. The spectra
were recorded using Bruker Avance Neo spectrometer (Faellanden, Switzerland) equipped
with an 11.74 T magnet (Larmor frequency of 500.38 MHz for 1H) and a 5 mm double
resonance Bruker Z-gradient Smart Probe and Bruker BSVT unit for temperature control.
The 1H and 13C NMR spectra were recorded in deuterium oxide (D2O) using RF pulses of
22 and 28 kHz, 16 and 1024 scans, and a recycle delay of 5 and 3.5 s, respectively, at 300 K
after waiting 10 min for sample temperature stabilization. The chemical shifts are reported
using δ scale and are externally referenced to TMS at 0.0 ppm.
The powder XRD analyses were performed with a Bruker D8 Advance diffractometer
(Karlsruhe, Germany) with Bragg–Brentano geometry, with Cu anode (radiation 1.5418 Å),
equipped with a Ni filter and operating at 40 kV and 40 mA. For non-mesoporous samples,
the 2θ interval explored was 5–60◦, with a time per step of 0.5 s and automatic synchroniza-
tion of the anti-scatter knife; the illumination area of the sample was fixed at 17 mm2. For
MCM-41 and MCM-41 NPs, the 2θ range measured was 1- 10◦, the height of the knife was
set to 0.4 mm, the area of illuminated sample and time per step were, respectively, 17 mm2
and 0.5 s.
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3. Results and Discussion
3.1. Ibu-Na Adsorption from Physiological Saline Solution
Nine different classes of inorganic adsorbents, tested for the removal of Ibu-Na from
the physiological saline solution, were selected considering their capacity for binding drugs
based on either ionic or non-covalent interactions. In Table 1, a comparative evaluation of
the maximum adsorption capacity of these adsorbents toward Ibu-Na from physiological
saline solution is reported.
Table 1. Ibu-Na adsorption capacity of various inorganic adsorbents from physiological
saline solution.
Adsorbents Adsorption (±2)% Loading (mg/g)
Cloisite-Na 0 0.02
Cloisite-Ca 4 0.16
Sieve (N.A.) 1 0 0.02
Sieve (Act.) 2 2 0.08
Hier ZSM-5 14 0.74
MCM-41 42 1.94
MCM-41 NPs 45 1.90
Silica gel 4 0.19
Fumed silica 4 0.17
1N.A.; not activated. 2 Act.; activated.
The ordered mesoporous silicas (MCM-41 and MCM-41 NPs) exhibited the best
adsorption capacity followed by hierarchical ZSM-5, amorphous silica and clays. To further
elucidate the physisorption mechanism and local packing of Ibu-Na into the surface of
the ordered mesoporous silica, time-resolved in situ MAS NMR spectroscopy and X-ray
powder diffraction studies were coupled.
3.2. Time-Resolved In Situ 13C and 1H MAS NMR Spectroscopy
To investigate the dynamics of the adsorption process of an active pharmaceuti-
cal ingredient on ordered mesoporous silica (MCM-41), a time-resolved study was per-
formed. The role of water in the interaction between active pharmaceutical ingredients
and MCM-41 surface was unclear from previous studies. It is assumed that the strong
affinity between water molecule and surface silanols may influence the adsorption of active
pharmaceutical compounds.
Highly resolved 13C NMR spectra of Ibuprofen can be obtained by either MAS or
CPMAS techniques and are extremely useful for determining the physical state of organic
molecules adsorbed on mesoporous materials. The 13C CPMAS is based on the transfer
of magnetization between 1H and 13C following heteronuclear dipolar coupling through
space and is, therefore, sensitive only to rigid molecules. On the other hand, the 13C MAS
NMR technique is able to detect both rigid and very mobile species, but using a short
relaxation time interval between accumulations, only the latter can be selectively detected.
The two techniques are, therefore, complementary and are used in synergy in this case,
together with the acquisition of 1H MAS NMR spectra, to obtain important information on
the state of Ibu-Na physisorbed on MCM-41.
13C NMR spectra of a physical mixture of Ibu-Na and MCM-41, before and after
treatment with D2O are reported in Figure 1. The spectral assignments are carried out with
the help of liquid-state NMR spectrum (Figure S1) and previous reports [35–38]. Before
contact with D2O, the spectra of physical mixture exhibited a typical 13C CPMAS NMR
spectrum of the Ibu-Na in solid state (Figure 1a). Nevertheless, the peak intensities and
chemical shifts indicate that only one peak is present for each 13C nuclei. However, upon
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contact with D2O, the 13C CPMAS NMR spectrum of physical mixture failed to record
signals and confirmed the absence of a residual crystalline solid phase in the mixture. As a
matter of fact, a similar experiment on a Ibu-Na/D2O (without the presence of MCM-41)
mixture resulted in the detection of 13C signals in a CPMAS NMR spectrum (Figure S2).
Figure 1. 13C CPMAS NMR spectra of physical mixture of Ibu-Na and MCM-41 before (a) and after contact with D2O (b). 13C
MAS NMR spectra of physical mixture after contact with D2O (c). The NMR spectra are recorded within 30 min of contact
with D2O. For comparison purpose, the 13C CPMAS NMR spectrum of IBU-Na is shown (d). Selected patterns of the 13C
time resolved in situ MAS NMR spectra of physical mixture after contact with D2O, time = 30 min (e), 420 min (f) and
2880 min (g). Inset shows the molecular structure of Ibu-Na form with the 13C labeling. * indicate peaks due to Kel-F insert
and probe background.
On the other hand, narrow 13C signals are displayed in the MAS NMR spectrum
(Figure 1c). Besides that, subtle changes in the chemical shift values are noted for selected
carbon atoms (Table S3). Previous reports have shown that characteristic changes in the
13C chemical shifts values can be considered as a fingerprint of confined ibuprofen located
in the mesopores [37,39], especially for carbon C9, which showed a difference of 2.3 ppm.
The failure of the CPMAS experiment in the presence of MCM-41 indicates a high degree
of mobility for Ibu-Na molecules inside the structure of mesoporous silica and strong
reduction in heteronuclear dipolar interactions. Therefore, it can be indisputably stated
that Ibu-Na molecules are packed inside MCM-41 mesopores. In addition, a narrow peak at
around 161 ppm was detected in the 13C spectra and is due to bicarbonate ions originating
from the trona and nahcolite (polymorphs of NaHCO3) present in the sample. This point
will be further demonstrated in the following section.
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The adsorption process was monitored in situ for two days; the selected pattern of
the time resolved study is reported in Figure 1e–g. No apparent change was observed in
the spectra, indicating that the packing of Ibu-Na into MCM-41 is a fast process and was
completed in the first minutes of contact. The high degree of mobility for Ibu-Na molecules
could arise due to specific motional modes, such as translational, rotational (both isotropic
reorientation of the molecules and rotation of isopropyl units or methyl groups) and the
flipping of phenyl moieties. Furthermore, the level of the pore filling and their physical
state were evaluated. The 13C MAS NMR spectra (Figure S3) are capable of revealing the
local molecular environments of Ibu-Na in various states, such as in a confined or liquid
state. Very subtle variations, such as differences in linewidth and changes in chemical shift
values, were noted among the spectra (Table S3). Moreover, two important differences
were noted for Ibu-Na molecules trapped inside the MCM-41 mesopores (Figure S3, insets).
They are not as highly mobile as in the liquid state (Figure S3 c, insets), as indicated by the
narrow linewidth; however, they are not as rigid as in molecules filled by mechanoloading
(broader peaks). The mesopores are probably filled jointly by D2O and Ibu-Na, leading to
their multimodal surface silanol interactions, that reflect the presence of both pore interface
and fluidic molecular species [40].
Indeed, a recent study noted that the freedom of motion is restricted in fully packed
mesopores compared to partially filled pores [39]. The implication of the 13C NMR spectral
observations is that dynamic disorder may exist when Ibu-Na adsorbs from water, while
static disorder, due to multiple adsorption sites and geometries, may dominate in the
mechanoloaded (without the assistance of any solvents) sample [41,42]. While the latter
process is predominantly surface docking in nature, leading to a distribution of 13C chemical
shifts, it can still be partially dynamic, as the mesopore surface can undergo rearrangement
in response to the transient molecular adsorption. The former process would allow the
faster adsorption of organic molecules on mesopore surfaces, assisted by the shuttling
capability of the solvent molecules from the bulk. Nevertheless, the water content, both
inside and outside the mesopores are the driving force of the adsorption process in such
systems, leading to a rapid averaging of the 13C resonance peaks, and may influence the
adsorption rate and mobility of the Ibu-Na molecules.
1H MAS NMR data provide further insights on the mechanism of molecular ad-
sorption. Prior to the time-resolved in situ 1H MAS experiments, the proton spectrum
of physical mixture was recorded (Figure S4). The 1H MAS NMR spectrum of MCM-41
(middle pattern) exhibited a sharp peak at around 2.27 ppm with a shoulder up-field (lower
ppm values) at 1.9 ppm, due to physisorbed water and isolated silanols, respectively. In
addition, a very broad peak in the range 2–7 ppm was also clearly visible and is due to
hydrogen bonding protons involving silanols and H2O. In the 1H MAS NMR spectrum
of the physical mixture, a peak due to isolated silanols was detected at 1.9 ppm; however,
the water peak was down-field shifted to 5 ppm. Furthermore, peaks due to Ibu-Na pro-
tons showed no apparent change in their chemical shift values. These NMR data reveal
that probably weak interactions between Ibu-Na molecules and MCM-41 surfaces are
already taking place in the physical mixture. In addition, low intensity peaks at around
13.8 and 18.3 ppm were detected and are attributed to the presence of nahcolite and trona,
respectively (polymorphs of NaHCO3) [43].
The stacked plot of time-resolved in situ 1H MAS NMR data is shown in Figure 2a,
recorded up to two days, showing exemplar results for the physisorption behavior of Ibu-
Na into MCM-41. A dramatic change in the appearance of spectral pattern is clearly evident
when one compares the 1H MAS NMR spectra recorded at time = 0 and time = 30 min.
Upon initial contact with D2O (time = 30 min), the Ibu-Na protons exhibited very sharp
resonance peaks, due to the motional averaging of the strong homonuclear 1H-1H dipolar
couplings. In addition, multiple resonances due to water molecules have started to emerge
in the 4.4 to 4.8 ppm range. The up-filed shift as well as the multiple δH values suggests
the presence of bulk water in diverse environments [44]. Peaks due to silanols are never
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detected in the hydrated physical mixture. One possible explanation for their absence is
that they are in fast chemical exchange with D2O.
Figure 2. Stacked plot of the time-resolved in situ 1H MAS NMR spectra (a) showing the rapid adsorption of Ibu-Na on
MCM-41 from physical mixture. Each spectrum was collected with 12 s of acquisition time. Selected patterns from the
time-resolved in situ 1H MAS NMR data showing the variations in peak intensity and linewidths as a function of time;
time = 30 min (c), 420 min (d) and 2880 min (e). For comparison purposes, the 1H MAS NMR spectrum of physical mixture
before contact with D2O is shown (b). Inset shows the molecular structure of Ibu-Na with 13C labelling.
Furthermore, the 1H resonances arising from the hydrogen bonded protons at 13.8 and
18.3 ppm are not detected in the hydrated physical mixture. As the dissolution of Ibu-
Na progressed further (time beyond 30 min), relative intensities of the resonance peaks
increased along with further homogeneous narrowing. The observed line widths are in
the range between 20 Hz and 80 Hz. A closer examination of the in situ 1H NMR spectra
(Figure 2d) showed that the maximum line narrowing for Ibu-Na protons is detected at
time = 420 min, beyond which further broadening is observed. Interestingly, the narrowest
line width for water peaks is also achieved at the same time interval.
Further quantitative information on the evolution of adsorption process and the
progress of mesopore filling in MCM-41 is obtained from the deconvolution of 1H MAS
NMR spectral data. In Figure 3, we show the deconvoluted 1H MAS NMR spectra, which
are typical for mixtures of rigid and mobile components with variable mobility, confirming
the multimodal distribution of the spectral signals. The undissolved Ibu-Na in the wet
physical mixture is represented by broadened aliphatic and aromatic 1H resonance peaks
(orange peaks). On the other hand, 1H MAS NMR spectra are dominated by very sharp
resonance lines with a very good resolution for a solid sample, even at moderate MAS
frequency of 12 kHz. This interpretation is further supported by a comparison of solid-state
and liquid-state 1H NMR data of Ibu-Na that reveal the spectral nature of the two states
(Figure S5).
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Figure 3. Time-resolved in situ 1H MAS NMR spectra, time = 30 min (a), 420 min (b) and 2880 min
(c) of the hydrated physical mixture (red) along with the deconvoluted spectrum (green) and the
individual contribution from each mobile 1H sites (black). The contributions from the solid Ibu-Na
are shown in broad orange peaks. Various water environments are shown in blue peaks.
Interestingly, at least two different sets of narrow resonances are clearly present for
each 1H site. The detection of two sets of sharper peaks highlights the presence of two
motional regimes within the physisorbed sample. Such sharp lines (line widths between
20 and 80 Hz) are due to motional averaging of the homonuclear 1H-1H dipolar couplings
coming from the reorientation of Ibu-Na in the mesopores of MCM-41. A closer examination
of the deconvoluted 1H MAS NMR spectra at different time intervals illustrated the diverse
intensity ratio between the two sets of sharper peaks. At the beginning of the adsorption
process, among the sets of sharper peaks, relatively broader resonances have dominated
the spectrum. However, at time = 420 min, narrower resonances emerged as the most
intense contributor to the spectrum. Toward the end of experimental study, the trend again
reversed, meaning some form of solidification was initiated.
The sharper resonances are due to Ibu-Na molecules encapsulated inside the meso-
pores, while the remaining fraction of narrow resonances are attributed to the hydrated
Ibu-Na molecules at the external surfaces. As the adsorption progressed in time, more
Ibu-Na molecules were filled in the pores. However, once the pores are completely filled,
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solidification of Ibu-Na was initiated. The presence of such distinct molecular ensembles
subjected to intrinsically diverse local molecular environments and exhibiting different
dynamical behavior was reported in organic molecules embedded in MCM-41 [45,46].
This hypothesis is further supported by the behavior of water molecules, which exhibited
diverse chemical environments within the MCM-41. When water is added, it can remain as
physical water or fill the mesopores or interact with surface silanol sites [47,48]. Therefore,
the diverse chemical shifts displayed in the 1H MAS NMR spectra can be attributed to water
molecules outside and inside the pore surfaces interacting with Ibu-Na molecules as well
as silanols. Nevertheless, the concurrent dynamic exchange between ’in’ and ‘out’ guest
molecules (water and Ibu-Na) explain the rapid adsorption kinetics at ambient temperature.
The interplay between various guest–guest and guest–host interactions co-present as either
London dispersion forces and/or as hydrogen bonds, and are responsible for adsorption
and extreme nanoconfinement.
3.3. Time-Resolved In Situ Powder X-ray Diffraction
It is also interesting to study the physisorption phenomenon from the crystallographic
point of view; for this purpose, time-resolved in situ powder X-ray diffraction studies
were carried out. In Figure 4, we show the powder XRD pattern of physical mixture
along with MCM-41 and Ibu-Na. The diffraction pattern of pure Ibu-Na displays its
high crystalline nature. The main peak at 3.73◦ 2θ corresponding to (001) Bragg peak is
particularly intensive and distinctive [49]. In addition, intense peaks at 11.21◦, 17.45◦,
17.88◦, 18.58◦, 19.03◦, and 19.77◦ 2θ are clearly visible. The MCM-41 displayed four typical
well-resolved low-angle XRD peaks, which can be indexed into (100), (110), (200) and
(210) Bragg peaks reflecting the 2D hexagonal symmetry, indicating the good structural
quality of MCM-41 [50]. Moreover, the XRD peaks associated to MCM-41 showed no shift
or broadening for the physical mixture. The main phases identified through the Bragg
peaks in the physical mixture are sodium salt of Ibuprofen (COD 4510388) and MCM-41.
In addition, traces of polymorphs of sodium bicarbonates, such as trona (COD 907656) and
nahcolite (COD 1011016) are also detected (Figure S6).
Figure 4. Powder XRD pattern of Ibu-Na, MCM-41 and their physical mixture.
Figure S7 depicts the Ibu-Na structural changes during the contact with water probed
by the time-resolved in situ powder XRD technique. Several representative powder XRD
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patterns, which show the dynamic crystal transformation during the uptake of water, are
selected and are presented in order to confirm the formation of the dihydrate state from
the anhydrous form. It is reported that the transition between the anhydrous to hydrated
state, and vice versa, of Ibu-Na is fast and can be found both as dihydrate and anhydrous
racemic compound or anhydrous conglomerate forms [49,51]. On the other hand, it is
known that the conversion of racemic anhydrous into hydrated state removes disorder
and leads to a more crystalline state [52]. Geppi and co-workers found that the anhydrous
form hydrated rapidly and the conversion was almost completed in an hour’s time [49].
As expected, the isostructural hydrated form remained stable over the course of the in situ
experimental study (Figure S7). These results are in line with the literature data [49,51].
Figure 5 displays time-resolved in situ powder XRD patterns collected during the
physisorption of Ibu-Na on MCM-41. The powder XRD data revealed that there are two
competing processes that occur simultaneously, namely, water uptake to form dihydrate
form and the physisorption of Ibu-Na into mesopores of MCM-41. Initially, the former
process dominates as the peaks of the anhydrous form at 3.82◦ 2θ decrease in intensity
and dihydrate forms as its reflection at 3.73◦ 2θ increases. However, at later stages, the
diffraction peaks associated to Ibu-Na start to gradually disappear as physisorption domi-
nates (Figure 5B). Thus, the Ibu-Na molecules embedded within the mesopore channels
are in a molecularly dispersed state with no long-range order. On the other hand, as
the impregnation process started, a significant decrease in the diffraction peak intensity
corresponding to the (100) reflection of MCM-41 was noted and is consistent with the
mesopore filling with Ibu-Na and water molecules [53]. Overall, the time-resolved in situ
powder XRD data suggest that the physisorption of Ibu-Na molecules into the pores of
MCM-41 occur rapidly and exist in an amorphous and stable state.
Figure 5. Time resolved in situ powder XRD patterns (A) collected during the physisorption of Ibu-Na on MCM-41. The
zoom version of the selected range showing the disappearance of diffraction peaks (B). The broad peak, between 8◦ and 16◦
2θ is due to background signal from the dome.
3.4. Ibu-Na Adsorption from Synthetic Urine
The adsorption of Ibu-Na from the synthetic urine medium onto selected inorganic
adsorbents was performed at pH = 6 (Table 2). Cloisite-based clays do not show any effi-
ciency in Ibu-Na adsorption from synthetic urine medium, and the electrostatic repulsion
between clay and Ibu-Na dominates, which mainly present as an anion. It is deduced that
in this setting, a drug like Ibu-Na fails to compete effectively for the active sites of the
clays. On the other hand, ordered mesoporous MCM-41 and hierarchical ZSM-5 showed
significant adsorption capacity.
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MCM-41 NPs 21 1.03
Hier ZSM-5 26 1.32
Ordered mesoporous MCM-41 is confirmed as the best adsorbent among the inorganic
matrixes, followed by hierarchical ZSM-5. The binding mechanism mainly proposed for
Ibu-Na adsorption on mesoporous silica is the formation of non-covalent interactions with
the pore surface. However, when one compares the adsorption of Ibu-Na from water and
synthetic urea, it is clear that there is a decrease in the adsorption capacity for the latter
system. It is also necessary to keep in mind the complex competition that may exist for
active sites in the mesopores between Ibu-Na and the organic components of synthetic
urine, such as urea and citrate. Urea is a neutral molecule that can efficiently form hydrogen
bonds, and citrate is a triprotic acid with pKa at 3.1, 4.8, 6.4, and could be more competitive.
In light of these data, it can be formulated that a significant percentage of PhACs could
also be removed from either water or synthetic urine, using adsorbents, such as MCM-41
or hierarchical ZSM-5.
Furthermore, the adsorption of Ibu-Na from synthetic urine medium at pH = 4
and pH = 8 was performed and the data are shown in Tables S4 and S5, respectively.
Exceptional adsorption capacities for Ibu-Na are displayed by ordered mesoporous MCM-
41 and hierarchical ZSM-5 at a pH value of 4. On the other hand, a significant drop in the
efficient adsorption and packing of Ibu-Na in the studied inorganic materials was noted at
a pH value of 8.
3.5. Raman Spectroscopy
The uptake process and the ensuing competition were monitored, using Raman spec-
troscopy. The acronym MCM-41\Ibu-Na_U identifies the sample we measured after the
Ibu-Na adsorption test from the synthetic urine medium. The Raman spectrum of MCM-
41\Ibu-Na_U sample (Figure 6) appears radically different from that of the corresponding
starting materials, such as Ibu-Na, urea, citrate and MCM-41. The disappearance of the
signal due to isolated silanols (3750 cm−1) and the appearance of bands due to O-H and
N-H groups (at 3620, 3478, 3393 and 3232 cm−1) are observed [54]. The Raman profile of
MCM-41\Ibu-Na_U is very similar to that of urea; similarities are evident in the range
3250–3500 cm−1, with three wide bands originating from the N-H stretching of the organic
molecule, and more indicatively, the intense peak at 1010 cm−1, attributable to the sym-
metrical stretching of C-N accompanied by a weaker signal at 1150 cm−1, its asymmetric
stretching appears instead at 1466 cm−1. Its contribution to the 1600–1660cm−1 band of
MCM-41\Ibu-Na_U is also evident: in this window, the stretching motions of the carbonyl
(1540 cm−1) and of deformation of the NH2 groups (1650 and 1620 cm−1) of urea fall [55].
In the range between 100 cm−1 and 1800 cm−1, significant differences between MCM-41
and MCM-41\Ibu-Na U are observed; in the spectrum of the latter, the silica signals are
dominated by the appearance of an intense peak centered at 1004 cm−1 accompanied by
a wide profile at 1100 cm−1 and a band clearly distinguishable at 1157 cm−1. A complex
band is present in the range 1600–1660 cm−1, probably originated from the addition of
several vibrational motions that fall into the region, and a weaker signal at 1460 cm−1,
being strongly asymmetrical.
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Figure 6. Raman spectra of MCM-41 (black), MCM-41\Ibu-Na_U (red), citrate (blue) urea (green),
Ibu-Na (orange).
From the spectra, it is possible to recognize the presence of Ibu-Na and citrate by the
signals at 2950 cm−1 and stretching region of C-H [56,57]. A slight shift in the peak of urea
C-N stretching is also visible (1010 cm−1). The region at 1400–1800 cm−1 appears very
complex; in this range, typical signals due to the stretching of the carbonyls of different
organic components of synthetic urine and to the deformation modes of the groups NH2
can be assigned. The broadening of signals may indicate their involvement in interactions
with silica or other molecules. In conclusion, urea is confirmed as the dominant component
in the Raman profile of MCM-41\Ibu-Na_U and is, therefore, supposed to constitute the
predominant fraction of organic molecules adsorbed on MCM-41, thus qualifying as the
main interfering factor in synthetic urine adsorption. On the other hand, the contribution of
citrate is limited. In Figure 7, we show a scheme describing the mechanism of transportation
and equilibrium adsorption of Ibuprofen from urine.
Figure 7. A scheme describing the mechanism of transport and equilibrium adsorption of Ibuprofen
from urine.
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4. Conclusions
This study has demonstrated that the emerging contaminants, such as drugs and
active pharmaceutical ingredients, can be effectively removed from polluted water or urine
at their source by adsorption. The optimum adsorbent materials for the easier removal of
drugs and metabolites were found to be ordered mesoporous silica (MCM-41), followed by
hierarchical zeolites and clays. The uptake process, the ensuing competition, the efficiency
and selectivity as well as the packing of model compound, Ibu-Na, in MCM-41 were all
thoroughly monitored by a novel approach involving time-resolved in situ 1H and 13C
MAS NMR spectroscopy as well as X-ray powder diffraction.
The time resolved in situ multinuclear MAS NMR spectroscopic study has successfully
illustrated the role of MCM-41 as an Ibu-Na carrier and adsorbent. The direct observation
of molecularly adsorbed Ibu-Na on the mesoporous surfaces of MCM-41 by MAS NMR
revealed the potentials of a newly designed time-resolved in situ NMR approach. Water
molecules facilitate the transportation and eventually the adsorption of organic molecules
on mesoporous surfaces; however, the cooperative and dynamic interactions between
water, silica surface and organic molecules are envisaged. Subsequently, in agreement with
the findings in this study, an improvement in the physisorption of active pharmaceutical
ingredients (API) can be achieved by employing ordered porous silica or high surface area
materials with the aid of solvents.
We have elucidated that by the meticulously designed time-resolved multinuclear
MAS NMR spectroscopy, it is possible to follow the adsorption of Ibu-Na in situ, for that
matter, any organic compound, to a porous system such as MCM-41 by incipient wetness
impregnation. The fundamental mechanistic steps of the encapsulation advancement with
time and the transient molecular adsorption as well as the final local molecular state of the
adsorbed Ibu-Na molecules in a wet porous sample, that are inaccessible by other means,
are established here. Furthermore, the time-resolved in situ X-ray diffraction approach
facilitates the monitoring of multi-step molecular adsorption, which complements the
NMR data. Finally, this study proposes the use of combined complementary in situ tools to
provide unprecedented insights as well as to establish and visualize complex processes,
such as molecular adsorption.
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Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/ma14206196/s1, Table S1: The concentrations and amounts of synthetic urine components used
throughout the experiments, Table S2: Parameters used for calculating the initial concentration of
active substance, Table S3: 13C chemical shift (ppm) assignments of Ibu-Na in liquid state, solid state,
confined state with and without water in MCM-41, Table S4. Adsorption of Ibu-Na from synthetic
urine at pH 4 on selected inorganic adsorbents. Table S5. Adsorption of Ibu-Na from synthetic
urine at pH 8 on selected inorganic adsorbents. Scheme S1: Tools for time-resolved in situ MAS
NMR experiments, 4 mm zirconia rotor and Kel-F cap (A), Kel-F insert, plug and screw (B). Tools
for time-resolved in situ powder XRD experiments, low background and airtight PMMA specimen
holder with a sample reception of 20 mm diameter silicon wafer with cavity (C), a dome like cap
equipped with a knife edge beam stop and a one Euro coin, Figure S1: 13C CPMAS NMR spectra of
ibuprofen in acid-form (a) and sodium salt-form (b) showing the differences in their crystallographic
states. For comparison purpose, the liquid-state NMR spectrum of ibuprofen in sodium salt-form
collected using D2O as solvent is also shown (c). Inset shows the molecular structure of ibuprofen in
sodium salt-form with the 13C labelling. * indicates peaks due to spinning side-bands, Figure S2: 13C
MAS (a) and CPMAS (b) NMR spectra of Ibu-Na mixed with D2O. The NMR spectra were recorded
within 10 min of contact between ibuprofen and D2O. For comparison purpose, the 13C CPMAS
NMR spectrum (c) of Ibu-Na before contact with D2O is also shown. * indicates peak due to probe
background, Figure S3: 13C MAS NMR spectra of physical mixture after 1200 min of contact with D2O
(a), Ibu-Na loaded in MCM-41 with mechanoloading (without any solvents) (b) and the liquid-state
NMR spectrum of Ibu-Na in D2O (c). Insets show the zoom spectra. * indicates peak due to either
probe background or Kel-F insert, Figure S4: 1H MAS NMR spectra of physical mixture (a) together
with the spectra of MCM-41 (b) and Ibu-Na (c), Figure S5: 1H MAS NMR spectra of ibuprofen in
acid-form (a) and sodium salt-form (b). For comparison purpose, the liquid-state NMR spectrum of
ibuprofen in sodium salt-form collected using D2O as solvent is also shown (c). Traces of NaHCO3
polymorphs (Trona and Nahcolite) are present in sample b. * denote solvent peak, Figure S6: Powder
XRD pattern of Ibu-Na along with the phase determination and identification using EVA software.
Peaks from Ibu-Na—COD 4510388 in orange, minor phases such as Trona—COD 907656 in cyan
and Nahcolite—COD 1011016 in green, Figure S7: Stacked plot of the time-resolved in situ powder
XRD patterns (A) collected during the sorption of water on Ibu-Na. The zoom version of the selected
range showing the identical diffraction patterns (B).
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48. Pajzderska, A.; Gonzalez, M.A.; Mielcarek, J.; Wąsicki, J. Water Behavior in MCM-41 As a Function of Pore Filling and Temperature
Studied by NMR and Molecular Dynamics Simulations. J. Phys. Chem. C 2014, 118, 23701–23710. [CrossRef]
49. Rossi, P.; Macedi, E.; Paoli, P.; Bernazzani, L.; Carignani, E.; Borsacchi, S.; Geppi, M. Solid–Solid Transition between Hy-
drated Racemic Compound and Anhydrous Conglomerate in Na-Ibuprofen: A Combined X-ray Diffraction, Solid-State NMR,
Calorimetric, and Computational Study. Cryst. Growth Des. 2014, 14, 2441–2452. [CrossRef]
50. Beck, J.S.; Vartuli, J.C.; Roth, W.J.; Leonowicz, M.E.; Kresge, C.T.; Schmitt, K.D.; Chu, C.T.W.; Olson, D.H.; Sheppard, E.W.;
McCullen, S.B.; et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc.
1992, 114, 10834–10843. [CrossRef]
51. Zhang, G.G.Z.; Paspal, S.Y.L.; Suryanarayanan, R.; Grant, D.J.W. Racemic species of sodium ibuprofen: Characterization and
polymorphic relationships. J. Pharm. Sci. 2003, 92, 1356–1366. [CrossRef]
52. Censi, R.; Martena, V.; Hoti, E.; Malaj, L.; di Martino, P. Sodium ibuprofen dihydrate and anhydrous. J. Therm. Anal. Calorim.
2012, 111, 2009–2018. [CrossRef]
53. Charnay, C.; Begu, S.; Tourné-Péteilh, C.; Nicole, L.; Lerner, D.; Devoisselle, J.-M. Inclusion of ibuprofen in mesoporous templated
silica: Drug loading and release property. Eur. J. Pharm. Biopharm. 2004, 57, 533–540. [CrossRef] [PubMed]
54. Socrates, G. Infrared and Raman Characteristic Group Frequencies: Tables and Charts, 3rd ed.; John Wiley and Sons, Ltd.: Chichester,
UK, 2004; Volume 35, ISBN 978-0-470-09307-8.
55. Keuleers, R.; Desseyn, H.O.; Rousseau, B.; van Alsenoy, C. Vibrational Analysis of Urea. J. Phys. Chem. A 1999, 103, 4621–4630.
[CrossRef]
56. Vueba, M.L.; Pina, M.E.; Batista de Carvalho, L.A.E. Conformational Stability of Ibuprofen: Assessed by DFT Calculations and
Optical Vibrational Spectroscopy. J. Pharm. Sci. 2008, 97, 845–859. [CrossRef] [PubMed]
Materials 2021, 14, 6196 19 of 19
57. Jubert, A.; Legarto, M.L.; Massa, N.E.; Tévez, L.L.; Okulik, N.B. Vibrational and theoretical studies of non-steroidal anti-
inflammatory drugs Ibuprofen [2-(4-isobutylphenyl)propionic acid]; Naproxen [6-methoxy-α-methyl-2-naphthalene acetic acid]
and Tolmetin acids [1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid]. J. Mol. Struct. 2006, 783, 34–51. [CrossRef]
